'Atypical'bacteria are a common cause of community-acquired pneumonia in hospitalised adults G Maartens, SJ Lewis, C De Goveia, C Bartie, D Roditi, KP Klugman South African Medical Journal 84 (10), 678-682, 1994 | 34 | 1994 |
‘Covering the tail’after stopping efavirenz-based antiretroviral therapy G Maartens Southern African Journal of HIV Medicine 21 (1), 2020 | 1 | 2020 |
2007 Rwanda Service Provision Assessment Survey.[Policy briefing kit]. JM Chakaya, T Young, CE Oliphant, I Araoyinbo, J Volmink, HS Schaaf, ... East African Medical Journal 85 (11), 521-2, 2008 | | 2008 |
3rd SA HIV Conference, Durban-track summaries G Maartens, N Shaikh, F Hassan, K Cullinan, I Meintjes-Moakes, ... Southern African Journal of HIV Medicine 2007 (28), 8-16, 2007 | | 2007 |
825 Severe Hepatotoxicity Associated with Nevirapine Use in HIV-Infected I Sanne, H Mommeja-Marin, J Hinkle, JA Bartlett, MM Lederman, ... | | |
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19â 22 July 2015, Vancouver, Canada KM Pate, C Pohlmeyer, V Walker‐Sperling, J Foote, K Najarro, C Cryer, ... International AIDS Society, 2015 | | 2015 |
A clinical prediction rule for PI resistance in resource-limited settings K Cohen, A Stewart, A Kengne, R Leisegang, M Coetsee, S Maharaj, ... 22nd Conference on Retroviruses and Opportunistic Infections (CROI), 23-26, 2015 | 1 | 2015 |
A clinical prediction rule for protease inhibitor resistance in patients failing second-line antiretroviral therapy K Cohen, A Stewart, AP Kengne, R Leisegang, M Coetsee, S Maharaj, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (3), 325-329, 2019 | 12 | 2019 |
A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV TH Boyles, M Nduna, T Pitsi, L Scott, MP Fox, G Maartens Open forum infectious diseases 7 (2), ofz543, 2020 | 15 | 2020 |
A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion D De Wit, G Maartens, L Steyn Tubercle and lung disease 73 (5), 262-267, 1992 | 140 | 1992 |
A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women TK Phillips, P Sinxadi, EJ Abrams, A Zerbe, C Orrell, NC Hu, K Brittain, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (3), 311-318, 2019 | 34 | 2019 |
A comparison of the population pharmacokinetics of rifampicin, isoniazid and pyrazinamide between hospitalized and non-hospitalized tuberculosis patients with or without HIV N Abdelgawad, M Chirehwa, C Schutz, D Barr, A Ward, S Janssen, ... Wellcome open research 7, 72, 2022 | | 2022 |
A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis L Verboven, S Callens, J Black, G Maartens, KE Dooley, S Potgieter, ... Research square, 2023 | 3 | 2023 |
A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein GG Alvarez, E Sabri, D Ling, DW Cameron, G Maartens, D Wilson The International journal of tuberculosis and lung disease 16 (9), 1247-1251, 2012 | 20 | 2012 |
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre DJ Van Hoving, G Meintjes, G Maartens, AP Kengne Wellcome Open Research 5, 2020 | 3 | 2020 |
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre. D Jacobus, G Meintjes, G Maartens, AP Kengne | | 2020 |
A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa R Leisegang, G Maartens, M Hislop, J Sargent, E Darkoh, S Cleary PloS one 8 (2), e53570, 2013 | 14 | 2013 |
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus–associated … AG Davis, S Wasserman, C Stek, M Maxebengula, C Jason Liang, ... Clinical Infectious Diseases 76 (8), 1412-1422, 2023 | 16 | 2023 |
A randomized controlled trial of intravenous N-acetylcysteine in the management of anti-tuberculosis drug–induced liver injury MS Moosa, G Maartens, H Gunter, S Allie, MF Chughlay, M Setshedi, ... Clinical Infectious Diseases 73 (9), e3377-e3383, 2021 | 35 | 2021 |
A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy C Orrell, K Cohen, K Mauff, DR Bangsberg, G Maartens, R Wood JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (5), 495-502, 2015 | 113 | 2015 |